Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Willicombe

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
The Journal of Infectious Diseases|August 4, 2023
Foreword: Preventing COVID-19 Among the Immunocompromised PopulationMichelle Willicombe
The International Journal of Artificial Organs|December 19, 2009
Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedanceAndrew Davenport, Michelle Willicombe
The Lancet. Infectious Diseases|November 10, 2022
SARS-CoV-2 vaccine strategies in kidney transplant recipientsMaria Prendecki, Michelle Willicombe
The Lancet. Infectious Diseases|June 26, 2021
Single-dose SARS-CoV-2 vaccination efficacy in the elderlyMaria Prendecki, Michelle Willicombe
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis: a sufficient reason to avoid gadolinium-based contrast in all patients with renal impairment?Michelle Willicombe, John Cunningham
Kidney International|August 24, 2024
Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipientsMichelle Willicombe, David J Roberts
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 21, 2025
The case for providing human leukocyte antigen-selected red cell transfusions-Are we there yet?Michelle Willicombe, David J Roberts
The New England Journal of Medicine|January 3, 2014
Complement-binding anti-HLA antibodies and kidney transplantationChristopher Lawrence, Candice Clarke, Michelle Willicombe
Journal of the American Society of Nephrology : JASN|April 22, 2020
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?Michelle Willicombe, David Thomas, Stephen McAdoo
Nature Reviews. Nephrology|October 20, 2021
COVID-19 vaccination in patients with immunity-mediated kidney diseaseMaria Prendecki, Michelle Willicombe, Stephen P McAdoo
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Infectious Diseases|August 4, 2023
Foreword: Preventing COVID-19 Among the Immunocompromised PopulationMichelle Willicombe
The International Journal of Artificial Organs|December 19, 2009
Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi-frequency bioimpedanceAndrew Davenport, Michelle Willicombe
The Lancet. Infectious Diseases|November 10, 2022
SARS-CoV-2 vaccine strategies in kidney transplant recipientsMaria Prendecki, Michelle Willicombe
The Lancet. Infectious Diseases|June 26, 2021
Single-dose SARS-CoV-2 vaccination efficacy in the elderlyMaria Prendecki, Michelle Willicombe
Seminars in Dialysis|January 30, 2008
Nephrogenic systemic fibrosis: a sufficient reason to avoid gadolinium-based contrast in all patients with renal impairment?Michelle Willicombe, John Cunningham
Kidney International|August 24, 2024
Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipientsMichelle Willicombe, David J Roberts
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 21, 2025
The case for providing human leukocyte antigen-selected red cell transfusions-Are we there yet?Michelle Willicombe, David J Roberts
The New England Journal of Medicine|January 3, 2014
Complement-binding anti-HLA antibodies and kidney transplantationChristopher Lawrence, Candice Clarke, Michelle Willicombe
Journal of the American Society of Nephrology : JASN|April 22, 2020
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?Michelle Willicombe, David Thomas, Stephen McAdoo
Nature Reviews. Nephrology|October 20, 2021
COVID-19 vaccination in patients with immunity-mediated kidney diseaseMaria Prendecki, Michelle Willicombe, Stephen P McAdoo
Pageof 10